IL2 and neoplasm: Adoptively transferred gp-100 TCR T cells conjugated to these NPs expanded more, demonstrating higher activity and better tumor control in a murine B16F10 melanoma metastasis model, with even lower toxicity, when compared to ACT combined with systemically administered IL-2 [204].